Immunogen | IMGN - Passifs Courants



Passifs Courants Changement Date
AbbVie USD 42.1B 1.19B 2026-03
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Amgen USD 24.96B 534M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Exelixis USD 370.98M 34.67M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 9.32B 2025-12